Sirolimus pharmacokinetic differences between children and adults

Pediatric Transplantation

Volumn 10, Issue 8, 2006, Pages 872-874

  Venkataramanan, Raman ^a   Sindhi, Rakesh ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN; CYTOCHROME P450; GLYCOPROTEIN P; RAPAMYCIN; TSUKUBAENOLIDE;

AREA UNDER THE CURVE; DRUG CLEARANCE; EDITORIAL; HALF LIFE TIME; HUMAN; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION;

ADULT; AGE FACTORS; AREA UNDER CURVE; CALCINEURIN; CHILD; CYCLOSPORINE; DRUG INTERACTIONS; ENZYME INHIBITORS; HALF-LIFE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; METABOLIC CLEARANCE RATE; SIROLIMUS; TACROLIMUS;

EID: 33750584966     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2006.00600.x     Document Type: Editorial

References (32)

1. SCHUBERT M, VENKATARAMANAN R, HOLT DW, et al. Pharmacokinetics of sirolimus and tacrolimus in pediatric transplant patients. Am J Transplant 2004: 4: 767-773.
2. TEJANI A, ALEXANDER S, ETTENGER R, GARY L, ZIMMERMAN J, EDWARD K, BRISCO DM. Safety and pharmacokinetics of ascending single doses of sirolimus in pediatric patients with stable chronic renal failure undergoing dialysis. Pediatr Transplant 2004: 8: 151-160.
3. ZIMMERMAN JJ, KAHAN BD. Pharmacokinetics of sirolimus in stable renal transplant patients after multiple oral dose administration. J Clin Pharmacol 1997: 37: 405-415.
4. BRATTSTROM C, SAWE J, TYDEN G, et al. Kinetics and dynamics of single oral doses of sirolimus in sixteen renal transplant recipients. Ther Drug Monit 1997: 19: 397-406.
5. GALLANT HAIDNER HL, TREPANIER DJ, FREITAG DG, et al. Pharmacokinetics and metabolism of sirolimus. Ther Drug Monit 2000: 22: 31-35.
6. SCHACHTER AD, MEYERS KE, SPANEAS LD, et al. Short sirolimus half life in pediatric renal transplant recipients on calcineurin inhibitor free protocol. Pediatr Transplant 2004: 8: 171-177.
7. SINDHI R, WEBBER S, VENKATARAMANAN R, et al. Sirolimus for rescue and primary immunosuppression in transplanted children receiving tacrolimus. Transplantation 2001: 72: 851-855.
8. SINDHI R, WEBBER S, GOYAL R, et al. Pharmacodynamics of sirolimus in transplanted children receiving tacrolimus. Transplant Proc 2002: 34: 1960.
9. MCALISTER VC, MAHALATI K, PELTIKIAN KM, et al. A clinical pharmacokinetic study of tacrolimus and sirolimus combination immunosuppression comparing simultaneous to separated administration. Ther Drug Monit 2002: 24: 346-350.
10. BOTTIGER Y, SAWE J, BRATTISTROM C, et al. Pharmacokinetic interaction between single oral doses of diltiazem and sirolimus in healthy volunteers. Clin Pharmacol Ther 2001: 69: 32-40.
11. BRATTSTROM C, SAWE J, JANSSON B, et al. Pharmacokinetics and safety of single oral doses of sirolimus (rapamycin) in healthy male volunteers. Ther Drug Monit 2000: 22: 537-544.
12. MAHALATI K, KAHAN BD. Clinical pharmacokinetics of sirolimus. Clin Pharmacol Ther 2001: 1001: 573-585.
13. ZIMMERMAN JJ, HARPER D, GETSY J, et al. Pharmacokinetic interactions between sirolimus and microemulsion cyclosporine when orally administered jointly and 4 hours apart in healthy volunteers. J Clin Pharmacol 2003: 43: 1168-1176.
14. ZIMMERMAN JJ. Exposure response relationship and drug interactions of sirolimus. AAPS J 2004: 6: e28.
15. WU FL, TSAI MK, CHAN RR, et al. Effects of calcineurin inhibitors on sirolimus pharmacokinetics during staggered administration in renal transplant recipients. Pharmacotherapy 2005: 25: 646-653.
16. UNDRE NA. Pharmacokinetics of tacrolimus based combination therapies. Nephrol Dial Transplant 2003: 18: i12-i15.
17. FILLER G, WOMILOJU T, FEBER J, et al. Adding sirolimus to tacrolimus based immunosuppression in pediatric renal transplant recipients reduces tacrolimus exposure. Am J Transplant 2005: 5: 2005-2010.
18. WEBB NJ, STEVENSON PJ, LEWIS MA, et al. Pharmacokinetics of tacrolimus in pediatric renal transplant patients. Transplant Proc 1948-1950: 202: 34.
19. WALLEMACQ PE, VERBEECK RK. Comparative clinical pharmacokinetics of tacrolimus in pediatric and adult patients. Clin Pharmacokinet 2001: 40: 283-295.
20. PRAZEPIORKA D, BLAMBLE D, HILSENBECK S, et al. Tacrolimus clearance is age dependent within the pediatric population. Bone Marrow Transplant 2000: 6: 601-605.
21. VENKATARAMANAN R, PRASAD T, SWAMINATHAN A, et al. FK506: Clinical pharmacokinetics. Clin Pharmacokinet 1995: 26: 404-430.
22. JAIN AB, FUNG JJ, TZAKIS AG, et al. Comparative study of cyclosporine and FK506 dosage requirements in adult and pediatric orthotopic liver transplant patients. Transplant Proc 1991: 23: 2753-2766.
23. CONLEY S, FLETCHNER S, ROSE G, et al. Use of cyclosporine in pediatric renal transplant recipients. J Pediatr 1985: 106: 45-49.
24. HOPPU K, KOSKIMIES O, HOLMBERG C, et al. Pharmacokinetically determined dosage in young children. Pediatr Nephrol 1991: 5: 1-4.
25. FILLER G, FOSTER J, BERARD R, MAI I, LE PAGE N. Age dependency of mycophenolate lofetil dosing in combination with tacrolimus after pediatric renal transplantation. Transplant Proc 2004: 36: 1327-1331.
26. DIPCHAND AI, PIETRA B, MCCRINDLE BW, et al. Mycophenolic acid levels in pediatric heart transplant recipients receiving mycophenolate mofetil. J Heart Lung Transplant 2001: 20: 1035-1043.
27. BENFIELD M, SYMONS J, BYNON S, et al. Mycophenolate mofetil in pediatric renal transplantation. Pediatr Transplant 1999: 3: 33-37.
28. ROBERTI I, REISMAN L. A comparative analysis of the use of mycophenolate mofetil in pediatric vs adult renal allograft recipients. Pediatr Transplant 1999: 3: 231-235.
29. VAN DAMME-LOMBAERTS R, WEBB N, HOYER P, et al. Single dose pharmacokinetics and tolerability of everolimus in stable pediatric renal transplant patients. Pediatr Transplant 2002: 6: 147-152.
30. BENEDETTI MS, BALTES EL. Drug metabolism and disposition in children. Fundam Clin Pharmacol 2003: 17: 281-299.
31. LEEDER S, KEARNS GL. Pharmacogenetics in pediatrics. Implications for practice. New Front Pediatr Drug Ther 1997: 44: 55-77.
32. KEARNS GL, ABDEL-REHMAN SM, ALANDER SW, et al. Development pharmacology - drug disposition, action and therapy in infant and children. N Engl J Med 2003: 349: 1157-1167.